BioScience Health Innovations (BHIC) Stock Price, News & Analysis
Company Description
BioScience Health Innovations, Inc. is an OTC-traded health and wellness company whose confirmed operating profile centers on Best 365 Labs, a wholly owned subsidiary focused on science-backed cellular health. Company materials describe Best 365 Labs as a business associated with NAD and mitochondrial optimization, with an emphasis on making natural health and wellness products accessible through scalable retail and e-commerce channels.
The company’s public commercial activity includes the modernization of Best 365 Labs’ Amazon presence through an e-commerce partnership covering product detail page optimization, brand storefront development, conversion-focused content, marketplace growth and operational infrastructure. The subsidiary’s retail strategy is tied to online marketplace commercialization and broader channel expansion, including the use of omnichannel distribution infrastructure for consumer health products.
BioScience Health Innovations is incorporated in Nevada and is publicly traded under the symbol BHIC on the OTC market. Recent regulatory records identify the company as an emerging growth company and state that it has no securities registered pursuant to Section 12(b) of the Exchange Act. The company’s current filings identify Bluffdale, Utah as its corporate location at the city and state level, and its regulatory history shows the former name NOWTRANSIT INC.
The company’s public-company record includes corporate governance and capital-structure actions. Filings document a completed one-for-four reverse split of the company’s common stock and board-level changes reported through Form 8-K. These disclosures frame BHIC as a small public operating company with a health and wellness subsidiary, OTC trading status and a developing e-commerce and retail-channel strategy.
Stock Performance
BioScience Health Innovations (BHIC) stock last traded at $4.22, up 6.74% from the previous close. Over the past 12 months, the stock has gained 5.4%. At a market capitalization of $48.1M, BHIC is classified as a micro-cap stock with approximately 11.4M shares outstanding.
BHIC Rankings
Latest News
BioScience Health Innovations has 1 recent news article. Key topics include partnership. View all BHIC news →
SEC Filings
BioScience Health Innovations has filed 5 recent SEC filings, including 2 Form 10-Q, 1 Form 8-K, 1 Form 10-K, 1 Form 1-A. The most recent filing was submitted on May 11, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BHIC SEC filings →
Financial Highlights
BioScience Health Innovations generated $5.7M in revenue over the trailing twelve months, retaining a 57.0% gross margin, operating income reached $719K (12.6% operating margin), and net income was $642K, reflecting a 11.3% net profit margin. Diluted earnings per share stood at $0.06. The company generated $172K in operating cash flow.
Upcoming Events
Short Interest History
Short interest in BioScience Health Innovations (BHIC) currently stands at 24 shares, down 87.6% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 73%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for BioScience Health Innovations (BHIC) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
BHIC Company Profile & Sector Positioning
BioScience Health Innovations (BHIC) operates in the Pharmaceutical Retailers industry within the broader Healthcare sector and is listed on the OTC Link.